Demonstrates enhanced pulmonary delivery of remdesivir using polymeric nano-in-microparticles, suggesting improved antiviral therapy options for COVID-19.
The COVID-19 pandemic underscored the urgent need for advanced drug delivery systems to enhance the safety and efficacy of existing antiviral therapies. This study presents an inhalable powder formulation of...
No takes yet. Share an insight, caveat, or question.
Sani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: